- Wednesday, February 9th 2022 at 16:00 - 17:00 UK (Other timezones)
- General participation info | Participate online | + Phone in Meeting ID: 972 4297 4350 Passcode: 205293 Find your local number: https://ucl.zoom.us/u/aedyEiW1A6
Psychosis is a sign of severe brain disorders including schizophrenia and is characterised by disturbances of perception such as hallucinations. These are subjective phenomena that have traditionally been difficult to study biologically.
We recently established a new behavioural-computational approach to capture hallucination-like perception in humans and mice alike. Using this approach, we found that hallucination-like perception increased after hallucinogenic manipulations in mice and correlated with self-reported hallucinations in humans. Using optical imaging, optogenetics and pharmacology in behaving mice, we found evidence for a causal role of striatal dopamine in psychosis-like perception. Computational modelling showed that hallucination-like perception occurred when expectations about upcoming stimuli were high.
Our results suggest that hallucination-like perception can serve as a translational marker of hallucinations humans and mice, and provide circuit-level evidence for the long-standing dopamine across hypothesis of psychosis. We propose that increased striatal dopamine biases perception to rely more on expectations, signalled by cortical inputs, as compared to sensory evidence, signalled by thalamic inputs, thereby producing hallucinations.
In our current work, we investigate neural and immunological upstream regulators of these psychosis-relevant neural circuit mechanisms. Thereby, we hope to identify new biological targets for the treatment of schizophrenia, and to understand how the brain generates perception.
Dr. Katharina Schmack
Clinical Group Leader
Francis Crick Institute
Division of Psychiatry
University College London